Orpa Nasal Spray contains Fluticasone Furoate 27.5 mcg, a potent synthetic corticosteroid with anti-inflammatory properties indicated for the treatment of allergic rhinitis and other nasal inflammatory conditions. The active ingredient acts locally on the nasal mucosa to reduce inflammation, edema, and nasal congestion by inhibiting multiple types of cells and mediators involved in the allergic response. Orpa Nasal Spray is indicated for relief of symptoms such as nasal congestion, sneezing, rhinorrhea, and nasal itching associated with seasonal and perennial allergic rhinitis. It may also be used in the management of nasal polyps and other inflammatory nasal disorders as prescribed by a healthcare professional. The recommended dosage should be strictly followed to minimize systemic absorption and potential corticosteroid-related adverse effects. Common side effects include nasal irritation, dryness, and occasional epistaxis. Patients should be advised to avoid spraying directly onto the nasal septum to reduce mucosal injury. Use during pregnancy and lactation should be considered only if the potential benefit justifies the potential risk to the fetus or infant. Orpa Nasal Spray should be used under medical supervision, and patients should report any signs of hypersensitivity or worsening symptoms promptly.